Minneapolis-based Inspire Medical also said that Amzak Health managing partner Joyce Erony left the board effective yesterday.
Ellis spent 27 years at Medtronic before retiring in 2016.
“On behalf of the entire Inspire board of directors, I would like to extend my appreciation to Joyce for her valuable guidance since her appointment as a director in November 2016, including serving as chair of the nominating and governance committee of the board,” president & CEO Tim Herbert said in prepared remarks. “We also welcome Gary to our board of directors and have confidence that he will have an immediate and positive impact on Inspire. I have known Gary for many years and he was highly supportive in the very early years during Inspire’s transition to an independent company.”
T2 Biosystems kicks CEO McDonough upstairs
T2 Biosystems (NSDQ:TTOO) this week said that founding CEO John McDonough was named chairman, effective immediately, as the MR-powered diagnostic device maker launches a search for a new chief executive.
“On behalf of the board, I would like to thank John, the founding CEO of our company, for guiding the company through its formative stages, initial public offering and early commercial years. We are particularly proud that under John’s leadership, the company has created a technology and market with a whole new approach to diagnostics and has received FDA clearance for three products that many believed were not possible. It is gratifying that we have seen the benefits of these products on patient care in the United States and outside the United States. The board looks forward to working closely with John as we begin the process to find the right person to lead the company through our next phase of growth. This process could take a number of months and we will make an announcement when we have a new CEO in place,” lead independent director Stanley Lapidus said in prepared remarks.
“It is personally the right time for me and I believe, the right time for T2 to begin the process of finding a successor for the CEO role. I have been honored to have worked diligently at the helm for 12 years and I look forward to working with our board of directors in the search process and fostering a smooth transition to my successor while moving to the non-executive chairman role,” McDonough added.
Cardiovascular Systems lures ex-Rep. Paulsen to board
Cardiovascular Systems (NSDQ:CSII) last week said it lured former U.S. Rep. Erik Paulsen (R-Minn.) as a director, replacing Scott Bartos, who is retiring from the board after seven years.
“During his time as a member of the United States House of Representatives, Erik was a strong advocate for the medical technology industry, the life-saving technologies it provides to patients and the hundreds of thousands of jobs it supports,” chairman, president & CEO Scott Ward saud ub prepared remarks. “His leadership and experience in government affairs will be invaluable as CSI seeks to expand the number of patients it serves.
“We thank Scott Bartos for his many contributions to CSI throughout the past seven years. During his tenure, over 400,000 patients benefitted from orbital atherectomy. Scott’s counsel helped shape CSI’s strategy as we transform this company from a single technology, single geography company to an innovative leader with worldwide reach,” Ward said.
AliveCor puts Amazon exec Abani in the corner office
AliveCor said last week that it put Amazon executive Priya Abani in the corner office, replacing Ira Bahr, who was named COO, effective July 29. The company also named Kohsla Ventures founder Vinod Kohsla as chairman of the board.
Iradimed names Natus Medical exec McDonnell as CEO
Iradimed (NSDQ:IRMD) appointed Leslie McDonnell, the former VP & GM of Natus Medical’s newborn care business, to be its president & CEO. McDonnell replaces Roger Susi effective August 19. Susi was named chairman & chief technology officer.